HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Para-NO-aspirin inhibits NF-κB and induces apoptosis in B-cell progenitor acute lymphoblastic leukemia.

Abstract
Although patients with acute lymphoblastic leukemia (ALL) usually achieve complete remission, disease relapse is common and difficult to treat. Para-NO-aspirin (para-NO-ASA) is a novel drug with demonstrated efficacy against a number of solid tumors and most recently chronic lymphocytic leukemia. In this study, we used ALL cell lines to assess the effects on cell viability by flow cytometry and investigated the mechanism of cell death using chemical inhibitors of key molecules and assessed the effects by flow cytometry, electrophoretic mobility shift assay, Western blotting, and quantitative reverse transcription polymerase chain reaction. Para-NO-ASA induced cell death in the pre-B ALL cell lines in association with increased reactive oxygen species, and suppression of nuclear factor-κB (NF-κB) activity. Chemical inhibitors of NF-κB similarly induced apoptosis in ALL cells, suggesting a role for suppression of NF-κB in para-NO-ASA-induced cell death. Modulation of NF-κB was not via regulation of IκB but potentially through suppression of ROCK1 and loss of reduced glutathione. Our results demonstrate that para-NO-ASA potently induces apoptosis in B-lineage ALL cells via a reactive oxygen species-dependent mechanism that is associated with suppression of NF-κB activity.
AuthorsNaveed I Khan, Adam Cisterne, Rana Baraz, Kenneth F Bradstock, Linda J Bendall
JournalExperimental hematology (Exp Hematol) Vol. 40 Issue 3 Pg. 207-215.e1 (Mar 2012) ISSN: 1873-2399 [Electronic] Netherlands
PMID22100881 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • NF-kappa B
  • Neoplasm Proteins
  • Nitric Oxide Donors
  • Reactive Oxygen Species
  • nitroxy-butyl-acetylsalicylic acid
  • ROCK1 protein, human
  • rho-Associated Kinases
  • Caspases
  • Glutathione
  • Aspirin
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Apoptosis (drug effects)
  • Aspirin (analogs & derivatives, pharmacology)
  • Caspases (metabolism)
  • Cell Line, Tumor (drug effects, metabolism)
  • Drug Screening Assays, Antitumor
  • Glutathione (metabolism)
  • Humans
  • NF-kappa B (antagonists & inhibitors)
  • Neoplasm Proteins (antagonists & inhibitors, metabolism)
  • Nitric Oxide Donors (pharmacology)
  • Oxidative Stress
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (pathology)
  • Reactive Oxygen Species (metabolism)
  • rho-Associated Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: